Nuveen
TECX

Nuveen’s Tectonic Therapeutic TECX Stock Holding History

Nuveen’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Buy
13,514
+1,481
+12% +$43.5K ﹤0.01% 3308
2026
Q1 		$372K Sell
12,033
-2,271
-16% -$55.9K ﹤0.01% 2945
2025
Q4 		$298K Hold
14,304
– – ﹤0.01% 3047
2025
Q3 		$224K Hold
14,304
– – ﹤0.01% 3128
2025
Q2 		$284K Buy
+14,304
New +$290K ﹤0.01% 3079
2022
Q2 		– Sell
-11,492
Closed -$218K – 3518
2022
Q1 		$218K Buy
11,492
+315
+3% +$6.51K ﹤0.01% 3175
2021
Q4 		$440K Sell
11,177
-3,073
-22% -$177K ﹤0.01% 3104
2021
Q3 		$1.06M Buy
14,250
+220
+2% +$18.1K ﹤0.01% 2973
2021
Q2 		$1.5M Buy
14,030
+2,876
+26% +$341K ﹤0.01% 2838
2021
Q1 		$1.7M Sell
11,154
-1,274
-10% -$207K ﹤0.01% 2693
2020
Q4 		$2.08M Buy
12,428
+450
+4% +$80K ﹤0.01% 2494
2020
Q3 		$1.87M Buy
11,978
+143
+1% +$28.8K ﹤0.01% 2418
2020
Q2 		$2.48M Buy
11,835
+2
+0% +$412 ﹤0.01% 2248
2020
Q1 		$2.21M Buy
11,833
+74
+0.6% +$17.4K ﹤0.01% 2139
2019
Q4 		$2.84M Sell
11,759
-1,584
-12% -$305K ﹤0.01% 2271
2019
Q3 		$2.26M Buy
13,343
+7,943
+147% +$1.8M ﹤0.01% 2347
2019
Q2 		$1.05M Buy
+5,400
New +$1.16M ﹤0.01% 2712

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Nuveen's TECX Position: Q2 2026 in Review

Nuveen increased its Tectonic Therapeutic (TECX) stake by 12% in Q2 2026, buying an estimated $43.5K and bringing the position to 13,514 shares worth $465K. The position accounts for ﹤0.01% of the portfolio, ranked #3308.

Nuveen first reported a position in TECX in Q2 2019 and has held it in 17 quarters since. The position peaked at $2.84M in Q4 2019. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Nuveen held 13,514 shares of Tectonic Therapeutic worth $465K as of Q2 2026.
  • Nuveen bought 1,481 Tectonic Therapeutic shares in Q2 2026, an estimated $43.5K.
  • Tectonic Therapeutic made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3308 holding.
  • Nuveen first reported a position in Tectonic Therapeutic in Q2 2019 and has held it in 17 quarters since.
  • Nuveen's Tectonic Therapeutic position peaked at $2.84M in Q4 2019.
  • 122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.